Hyderabad’s AIG Hospitals has launched a new pharmacogenomics test that helps doctors pick the right medicines based on a person’s genes. This affordable tool, priced at just 5,000 rupees, aims to improve treatment outcomes and cut side effects for patients across India.
What the New Test Offers
This genetic test looks at how a person’s body processes common drugs. It covers treatments for heart issues, diabetes, cancer, stomach problems, brain conditions, mental health, and pain relief.
Doctors can use the results to avoid medicines that might not work or cause harm. The test gives lifelong guidance, so patients get a report they can share with any doctor.
A recent study by the hospital checked over 2,000 people. It found that about 30 percent took drugs that did not match their genes. This often led to weak results or bad reactions.
The test costs much less than similar ones abroad, which can run up to 80,000 rupees. This makes personalized medicine open to more people in India.
How the Test Process Works
Patients start with a simple blood draw of just 2 milliliters at the hospital. Experts then pull out DNA and check it with advanced machines.
The analysis creates a custom report on drug responses. Results come back in a few weeks, ready for doctors to use.
This method uses proven tech to handle large amounts of gene data. It ensures accurate advice for safer prescriptions.
Many experts see this as a big step in health care. It fits with global trends toward gene-based treatments.
Benefits for Patients and Doctors
People gain from fewer trial-and-error treatments. This can save money on wrong medicines and reduce hospital visits.
Doctors get clear data to make smarter choices. It helps in tough cases where standard drugs fail.
Here are key advantages:
- Cuts risks of side effects from mismatched drugs.
- Speeds up recovery by picking effective options right away.
- Works for life, no need for repeat tests.
In India, where many face chronic illnesses, this test could change how care happens. It ties into efforts to bring modern tech to everyday health.
Study Findings and Impact
The hospital worked with partners to test the idea on real patients. They saw that one in three Indians might not respond well to standard doses.
This matches wider research showing genes play a big role in drug effects. For example, some need higher amounts, while others risk overload.
| Condition | Percent Affected by Gene Mismatch | Common Issue |
|---|---|---|
| Heart Disease | 25% | Ineffective blood thinners |
| Diabetes | 35% | Poor sugar control |
| Cancer | 28% | Strong side effects |
| Mental Health | 32% | No mood improvement |
These numbers highlight why gene testing matters. The hospital plans to talk with government groups to add it to public programs.
This could help millions, especially in rural areas with limited access.
Future of Personalized Medicine in India
India is pushing for more custom health solutions. This launch comes as other labs offer similar tests, but at higher prices.
Global trends show pharmacogenomics growing fast. By 2025, experts predict more widespread use in Asia.
The hospital aims to expand access. They want to train more doctors on using these reports.
Patients can ask about the test during visits. It starts a new era where medicine fits each person’s unique makeup.
What do you think about gene-based prescriptions? Share your views in the comments and spread the word to help others learn about this breakthrough.
